Clinical Quick Reference — Exercise Prescription, Risk Stratification, and Sports Participation
The 2020 ESC Guidelines provide evidence-based recommendations for exercise and sports participation in individuals with established or suspected cardiovascular disease (CVD). The goal is to minimize the risk of adverse cardiac events while maximizing the benefits of physical activity and quality of life.
| Class | Definition | Wording |
|---|---|---|
| I | Evidence or consensus that the procedure/treatment is beneficial, useful, effective | Is recommended or indicated |
| IIa | Weight of evidence/opinion in favour of the usefulness/efficacy | Should be considered |
| IIb | Usefulness/efficacy is less well established | May be considered |
| III | Evidence or consensus that the procedure/treatment is not beneficial and may be harmful | Is not recommended |
Young athletes (<35 years): ECG screening outperforms history and physical examination in all statistical measures of performance. 1
Older adults (≥35 years): Higher prevalence of atherosclerotic coronary artery disease (CAD). Screening should target CAD risk, including a 10-year ASCVD risk assessment. 1
| Component | Details & Recommendation |
|---|---|
| History | Personal and family history of sudden cardiac death, syncope, palpitations, dyspnea, chest pain, prior cardiac diagnosis. 1 |
| Physical Exam | Blood pressure, auscultation for cardiac murmurs, signs of inherited conditions (Marfan syndrome, aortopathy). 1 |
| 12-Lead ECG | Standard for young athletes; recommended in older athletes with symptoms or SCORE ≥1%. 1 |
| Echocardiography | Indicated if history/exam abnormal, ECG abnormalities, or as part of structural disease assessment. 2a |
| Exercise Testing | Consider in those ≥35 years planning vigorous sports, especially with risk factors or borderline SCORE. 2a |
| Risk Category | Key Features |
|---|---|
| Very High-Risk | Documented ASCVD; prior MI, ACS, unstable angina, PCI, CABG; CAC ≥300 AU; SCORE ≥10%; severe CKD |
| High-Risk | Asymptomatic with single high-risk feature; elevated LDL >4.9 mmol/L; SCORE 3–5%; CKD Stage 3b |
| Moderate-Risk | Young patients with T1DM <35 years; T2DM <50 years; SCORE 1–3% |
| Low-Risk | Calculated SCORE <1% for 10-year fatal CVD risk |
Use the ASCVD Risk Calculator for 10-year risk estimation in those ≥35 years.
Sports are classified by their predominant muscular work type (skill, power, mixed, endurance) and intensity of exercise (low, moderate, high).
| Skill Sports | Power Sports | Mixed Sports | Endurance Sports | ||||
|---|---|---|---|---|---|---|---|
| Low Golf (buggy), Table tennis (doubles) |
Mod Golf (walking), Bowling, Sailing |
Low Shot putting, Discus, Judo |
Mod Shot putting (comp), Wrestling, Boxing |
Low Soccer (adapted), Handball (adapted), Volleyball |
Mod Soccer (comp), Basketball, Tennis, Ice Hockey |
Low Jogging, Walking, Swimming (rec) |
Mod Running, Cycling, Long-distance swimming |
| High Weightlifting, Wrestling, Boxing |
High Competitive soccer/basketball |
High Sprint running, X-country skiing, Triathlon, Rowing |
|||||
| Zone | VO₂max (%) | HRmax (%) | HRR (%) | RPE | Training Zone |
|---|---|---|---|---|---|
| Low Intensity | <40 | <55 | <40 | 10–11 | Aerobic |
| Moderate Intensity | 40–69 | 55–74 | 40–69 | 12–13 | Aerobic |
| High Intensity | 70–85 | 75–90 | 70–85 | 14–16 | Aerobic + Lactate |
| Very High Intensity | >85 | >90 | >85 | 17–19 | Aerobic + Lactate + Anaerobic |
| Population & Goal | Recommendation | Class |
|---|---|---|
| All healthy adults | At least 150 min/week of moderate-intensity, or 75 min/week of vigorous-intensity aerobic exercise is recommended. 1 | I |
| Additional benefits | 300 min/week moderate-intensity or 150 min/week vigorous-intensity aerobic exercise is recommended for additional benefits. 1 | I |
| Frequency | Multiple sessions spread throughout the week (4–5 days/week preferably every day) are recommended. 1 | I |
| CAD Status | Recommendation | Class |
|---|---|---|
| Long-standing stable CCS with good capacity | Eligible for competitive and leisure sports activities with few exceptions. 2a | IIa |
| Recreational athletes with CAD | May be considered for low- to moderate-intensity recreational activities if exercise capacity ≥7 METs and normal imaging. 2a | IIa |
| After acute ACS | Avoid competitive sports and high-intensity recreational exercise initially; resume after 4–6 weeks with functional testing. 2a | IIa |
Use the ASCVD Risk Calculator to estimate 10-year ASCVD risk for CAD risk reassessment.
| HF Type & Status | Recommendation | Class |
|---|---|---|
| HFrEF | Aerobic and resistance training both improve functional capacity. 3–7 days/week moderate intensity (~30 min) recommended. 1 | I |
| HFpEF | Exercise training should be considered for symptoms improvement and functional capacity. 2a | IIa |
| Competitive sports | Recreational and leisure-time sports recommended if desired, avoiding competition. 2a | IIa |
| Severity (MVA) | Recommendation | Class |
|---|---|---|
| Mild (1.5–2.0 cm²) | All recreational sports recommended if resting sPAP <40 mmHg and normal exercise test. 1 | I |
| Moderate (1.0–1.5 cm²) | Low and moderate intensity recreational sports may be considered. 2b | IIb |
| Severe (<1 cm²) | Leisure sports of moderate or high intensity not recommended. 3 | III |
| HCM Risk Status | Recommendation | Class |
|---|---|---|
| Low-risk HCM | Participation in individualized leisure-time exercise at moderate intensity recommended. 1 | I |
| High-risk HCM | Competitive sports not recommended. Low-intensity recreational exercise may be considered. 2a | IIa |
Use the HCM SCD Risk Calculator to estimate 5-year sudden cardiac death risk in HCM.
| DCM Status | Recommendation | Class |
|---|---|---|
| Mild-moderate systolic dysfunction | Low- to moderate-intensity recreational exercise should be considered. 2a | IIa |
| Severe LV dysfunction | High/very high-intensity exercise and competitive sports not recommended. 3 | III |
| AF Status | Recommendation | Class |
|---|---|---|
| AF prevention | Regular physical activity recommended to prevent AF. 1 | I |
| With AF | Evaluation and management of structural heart disease and primary causes of AF recommended before sports participation. 1 | I |
| LQTS Status | Recommendation | Class |
|---|---|---|
| Symptomatic LQTS | Beta-blockers at target dose recommended for all exercising individuals with prior syncope/cardiac arrest. 1 | I |
| Competitive sports with QTc ≥470 ms (M) or ≥480 ms (F) | Not recommended in genetically confirmed LQTS. 3 | III |
| Brugada Status | Recommendation | Class |
|---|---|---|
| Symptomatic Brugada | ICD implantation recommended in patients with inducible SCD syncope and/or aborted SCD. 1 | I |
| Post-ICD sports | Resumption of leisure or competitive sports after shared decision-making if no recurrent arrhythmias over 3 months post-implant. 2a | IIa |
Use the QTc Calculator to assess QT interval corrected for heart rate, and the Brugada Risk Calculator for risk stratification.
| Aortic Pathology | Risk Category | Advice | Follow-up |
|---|---|---|---|
| Aorta <40 mm in BAV; Turner without aortic dilatation | Low | All sports permitted; endurance preferred over power | Every 2–3 years |
| 40–45 mm in BAV; PIFHS without dilatation | Low-Intermediate | Avoid high intensity power/contact sports; endurance preferred | Every 1–2 years |
| Moderate aortic dilatation (45–50 mm BAV) | Intermediate | Skill or mixed endurance sports at low intensity only | Every 6 months–1 year |
| Severe aortic dilatation (≥50 mm) | High | Sports contraindicated (temporarily) | Re-evaluation after treatment |
CHD recommendations must be individualized based on:
| Recommendation | Class |
|---|---|
| Participation in regular moderate exercise recommended in all individuals with CHD. 1 | I |
| Discussion on exercise participation and individualized exercise prescription recommended at every CHD patient encounter. 1 | I |
| Assessment of ventricular function, pulmonary artery pressure, aortic size, and arrhythmia risk recommended in all CHD athletes. 1 | I |
| Competitive sports should be considered for CHD athletes in NYHA class I or II without serious arrhythmias after individual evaluation. 2a | IIa |
| Competitive sports not recommended for NYHA class III–IV or with potentially serious arrhythmias. 3 | III |
| Recommendation | Class |
|---|---|
| 150 min/week moderate-intensity endurance training + 3× weekly resistance exercise recommended for individuals with obesity intending to engage in high-intensity exercise programmes. 1 | I |
| BP Category | Recommendation | Class |
|---|---|---|
| Controlled (SBP <140, DBP <90) |
Moderate-intensity dynamic aerobic exercise 5–7 days/week; resistance training highly effective. 1 | I |
| Uncontrolled | Postpone sports until BP controlled. Avoid intensive resistance training and isometric exercise. 2a | IIa |
| Recommendation | Class |
|---|---|
| Aerobic and resistance training combination effective for glycaemic control, BP reduction, weight loss, and dyslipidaemia. 1 | I |
| CV assessment (Figure 4) before high-intensity sports participation recommended; include glycaemic status and hypoglycaemia risk assessment. 2a | IIa |
| Recommendation | Class |
|---|---|
| Exercise testing should be considered for diagnostic purposes in sedentary individuals and those with high CV risk intending to engage in intense exercise. 2a | IIa |
Use these evidence-based tools to guide clinical decisions in sports cardiology and CV risk stratification:
Estimate 5-year risk of sudden cardiac death in hypertrophic cardiomyopathy using the ESC/ACC model.
Estimate 10-year ASCVD risk in primary prevention; useful for older athletes and CAD risk assessment.
Calculate QT interval corrected for heart rate using Bazett or Fridericia formulas; identify LQTS risk.
Assess 2-year stroke risk in athletes with atrial fibrillation and guide anticoagulation decisions.
Estimate operative mortality risk in cardiac surgery; useful for pre-operative assessment.
Assess risk of arrhythmia and sudden cardiac death in Brugada syndrome; guide ICD decisions.
Citation: Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96. DOI: 10.1093/eurheartj/ehaa605
Note: This quick reference is not a substitute for the full guideline. Always consult the complete ESC Guidelines and individual patient circumstances when making clinical decisions.